249 related articles for article (PubMed ID: 34884696)
41. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.
Gurzu S; Silveanu C; Fetyko A; Butiurca V; Kovacs Z; Jung I
World J Gastroenterol; 2016 Aug; 22(30):6764-75. PubMed ID: 27570416
[TBL] [Abstract][Full Text] [Related]
42. The role of cancer stem cells in pathogenesis of colorectal cancer.
Szaryńska M; Olejniczak A; Kmieć Z
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1469-1482. PubMed ID: 28100854
[TBL] [Abstract][Full Text] [Related]
43. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.
Kim SL; Lee ST; Min IS; Park YR; Lee JH; Kim DG; Kim SW
Cancer Sci; 2017 Nov; 108(11):2176-2186. PubMed ID: 28859238
[TBL] [Abstract][Full Text] [Related]
44. Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence.
Cui G; Xu G; Zhu L; Pang Z; Zheng W; Li Z; Yuan A
Oncotarget; 2017 Jul; 8(28):45311-45322. PubMed ID: 28484082
[TBL] [Abstract][Full Text] [Related]
45. Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.
Lei Z; Xiaomin Y; He H; Jian C; Xiaowu X
J Cell Physiol; 2019 Feb; 234(2):1369-1379. PubMed ID: 30076725
[TBL] [Abstract][Full Text] [Related]
46. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
47. ID4 predicts poor prognosis and promotes BDNF-mediated oncogenesis of colorectal cancer.
Ha CT; Cheng CY; Zheng MY; Hsu TH; Miao CC; Lee CJ; Wang HD; Pan ST; Chou YT
Carcinogenesis; 2021 Jul; 42(7):951-960. PubMed ID: 33993270
[TBL] [Abstract][Full Text] [Related]
48. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
49. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Kang S; Oh SC; Min BW; Lee DH
Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
[TBL] [Abstract][Full Text] [Related]
50. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
51. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells.
Wang Y; Liu Y; Lu J; Zhang P; Wang Y; Xu Y; Wang Z; Mao JH; Wei G
Biochem Biophys Res Commun; 2013 May; 434(2):352-6. PubMed ID: 23558291
[TBL] [Abstract][Full Text] [Related]
52. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
53. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
54. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer.
Zhu QC; Gao RY; Wu W; Qin HL
Asian Pac J Cancer Prev; 2013; 14(5):2689-98. PubMed ID: 23803016
[TBL] [Abstract][Full Text] [Related]
55. B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells.
Zhi Y; Mou Z; Chen J; He Y; Dong H; Fu X; Wu Y
PLoS One; 2015; 10(8):e0135528. PubMed ID: 26284927
[TBL] [Abstract][Full Text] [Related]
56. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
[TBL] [Abstract][Full Text] [Related]
57. Epithelial-to-mesenchymal transition and cancer stem cells: emerging targets for novel cancer therapy.
Kwon M
Cancer Gene Ther; 2014 May; 21(5):179-80. PubMed ID: 24882213
[No Abstract] [Full Text] [Related]
58. Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.
Skarkova V; Kralova V; Vitovcova B; Rudolf E
Cells; 2019 Mar; 8(3):. PubMed ID: 30871055
[TBL] [Abstract][Full Text] [Related]
59. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
[TBL] [Abstract][Full Text] [Related]
60. Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
Teo WH; Chen HP; Huang JC; Chan YJ
Int J Oncol; 2017 Nov; 51(5):1415-1426. PubMed ID: 29048611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
